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Summary 
Leukocyte adhesion molecules on endothelial cells of the blood-brain barrier may participate in 
the entry of leukocytes into the central nervous system. Because astrocytes are also a component 
of the blood-brain barrier  and have been associated with inflammation,  we studied the ability 
of astrocytes to express leukocyte adhesion molecules using Northern blot and immunocytochemical 
techniques. Astrocytes treated with the proinftammatory cytokine tumor necrosis factor c~ (TNF) 
expressed messenger RNA for the adhesion molecules E-selectin, vascular cell adhesion molecule 
1, and intercellular  adhesion molecule 1, as well as their corresponding  proteins.  In addition, 
TNF-treated  astrocytes expressed a  monocyte adhesion  protein  identified by our  laboratory, 
recognized by the monoclonal antibody IG9. These results indicate that  under inflammatory 
conditions in the central nervous system, such as multiple sclerosis and acquired immune deficiency 
syndrome, astrocyte expression of adhesion molecules may facilitate the migration of leukocytes 
and contribute  to the disease process. 
ukocyte adhesion  molecules participate  in  the  rolling, 
adhesion, and extravasation of leukocytes across the vas- 
cular endothelium  (1,  2).  Upregulation  of adhesion mole- 
cule expression on endothelial cells (EC) 1 has been demon- 
strated in immune-mediated diseases (3-9). Because immune 
cells are detected within the central nervous system (CNS) 
in diseases such as multiple sclerosis (10) and AIDS (11), adhe- 
sion molecules may facilitate the transmigration of leukocytes 
through  the blood-brain barrier  (BBB) and into the CNS, 
thereby contributing to the neuropathology of these diseases 
(5, 12). 
In addition  to EC, astrocytcs  are a structural  and func- 
tional  component of  the BBB (13-15).  Astrocyte  processes 
are  found  in  close  apposition  to  the  abluminal  surface  of  the 
endothclium and  have  been shown to  contribute  to  the  for- 
mation of  the  BBB (14,  15).  Astrocytes  can also  participate 
in  immune-mediated  events  (16-21).  For  example,  in  animal 
models of  autoimmune disease  as well  as in tissue  culture, 
astrocytes  can  present  antigen  to  MHC-rcstricted  T lympho- 
cytes  (16-21).  Also,  astrocytes  can respond to cytokines  by 
uprcgulating  their  MHC  antigen  expression  (19-21)  and  by 
secreting  additional  cytokincs  (21,  22).  Recently,  several  studies 
have  shown  that  astrocytes  can  be  induced  to  express  the  leu- 
1  Abbreviations used in this  paper: BBB, blood-brain barrier; CNS, central 
nervous system; EC, endothdial cells; ICAM 1, intercellular adhesion 
molecule 1; VCAM-1; vascular cell adhesion molecule 1. 
kocyte adhesion molecule, intercellular adhesion molecule 1 
(ICAM-1) (20, 23-25). Because neurologic dysfunction is a 
prominent finding in pediatric AIDS and the precise patho- 
genic mechanism is as yet undefined, we determined if human 
fetal astrocytes can express a repertoire of leukocyte adhesion 
molecules in response to the proinflarnmatory cytokine, tumor 
necrosis factor oe (TNF). 
Materials and Methods 
Source of Fetal Tissue.  The present study is part of an ongoing 
research protocol  that  has been approved by the Albert Einstein 
College of Medicine Committee on Clinical Investigation and the 
City of New York Health and Hospitals Corporation.  Informed 
consent was obtained from all participants. Fetal tissues were ob- 
tained at the time of elective termination of intrauterine pregnancy 
from otherwise normal healthy females. Gestational age was deter- 
mined by multiple parameters including the date of the last men- 
strual period by history, uterine size by bimanual and abdominal 
examination, ultrasonography using predominantly the maximum 
biparietal diameter, and, postabortally, by measurement of the fetal 
foot length (26). The tissues used in this study were obtained from 
21-23 wk-old fetuses. 
Cell Culture.  Astrocyte cultures were prepared according to the 
protocol of McCarthy and de VeUis (27). Briefly, human fetal CNS 
tissue was separated from the meninges, minced, and digested in 
0.25% trypsin (Gibco Laboratories, Grand Island, NY)/0.1% col- 
lagenase (Sigma Chemical Co., St. Louis, MO). The resulting cell 
suspension was serially  faltered through sterile 120- and 80-/~m nylon 
mesh filters (Tetko, Elmsford, NY) and pelleted at 900 rpm. Cul- 
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(Whittaker M. A. Bioproducts, Walkersville, MD). To enrich for 
astrocytes,  cultures were passaged after trypsinization. Astrocytes 
were treated with 400 U/ml TNF (endotoxin <1 ng/5  x  104 U 
TNF) (R&D  Research)  for 5 or 16 h. 
Northern Blot Analysis.  Total RNA was extracted from three 
sets of untreated and TNF-treated astrocyte cultures according to 
the method of Chomczynski and Sacchi (28).  RNA samples (20 
#g) were denatured and fractionated on 1% agarose gels prepared 
in  6.5%  formaldehyde/Ix  MOPS buffer.  After electrophoresis, 
RNA was transferred to a nitrocellulose filter and hybridized with 
the  following  32p  random  primer-labeled  (Amersham  Corp., 
Arlington Heights, IL) cDNA probes: E-selectin (29) (6.0-kb cDNA 
in  pCDN-Tm+4  vector),  vascular  cell  adhesion  molecule  1 
(VCAM-1)  (30)  (6.5-kb insert in pCDN  vector) (both provided 
by Dr. Walter Newman, Otsuka America Pharmaceuticals,  Rock- 
ville, MD), or ICAM-1 (31) (4.8-kb insert in CDM8 vector, provided 
by Dr. Timothy Springer, Center for Blood Research, Harvard Med- 
ical School, Boston, MA). To demonstrate equivalent loading of 
RNA, filters were stripped of radiolabeled  probe by boiling and 
rehybridized with a cDNA probe to human 18S RNA (32). Previous 
studies have used 18S RNA expression as a control for gene expres- 
sion  in astrocytes (33). 
Immunocytochemistry.  Astrocyte cultures were washed,  fixed in 
cold absolute methanol for 10 min, rinsed, and treated with a solu- 
tion  of 5%  nonfat milk  in  PBS  to block  nonspecific  antibody 
binding. Astrocytes were then incubated with one of the following 
primary antibodies  for 2  h:  anti-Glial Fibrillary Acidic  Protein 
(GFAP) (IgG1, 1:200; Boehringer Mannheim Biochemicals,  Indi- 
anapolis, IN), anti-ELAM-1 (IgG1, 1:100; Biodesign International, 
Kennebunkport, ME), anti-VCAM-1  (IgG1, F(ab')2, 2.9 mg/ml, 
1:200;  Dr. Walter Newman,  Otsuka America Pharmaceuticals), 
IG9 (IgG3, ascites,  1:2,000),  anti-ICAM-1  (1:100; Biodesign In- 
ternational), and anti-factor VIII-rehted antigen (IgG1, 1:100; Dako 
Corp., Santa Barbara,  CA).  After washing the cells, peroxidase- 
coupled, class-specific secondary antibodies were added.  Immuno- 
reactivity was visualized using diaminobenzidine (Sigma Chemical 
Co.). Immunocytochemical results  are representative of six sepa- 
rate experiments using cultures derived from different specimens. 
ELISA.  Astrocytes cultured in 96-well dishes were treated with 
TNF for 4,  16, 24,  or 48 h and thereafter fixed in cold absolute 
methanol.  Subsequently,  all steps were as detailed  above, except 
that tetramethylbenzidine (TMB; Boehringer Mannheim Biochem- 
icals) was used as a chromagen. After incubation with a peroxidase- 
coupled antibody, cultures were washed,  and  100 #1 TMB (0.1 
mg/ml)/H202 (0.3%) solution was added to each well. The reac- 
tion was stopped by the addition of 25 #1 8 N  sulfuric acid and 
the absorbance measured at OD 450 nm using an EIA reader (Bio- 
Rad Laboratories,  Richmond, CA).  Values represent the average 
of quadrnplicates  +1 SD. The histogram presented in Fig. 4 is rep- 
resentative of five experiments each using astrocytes from different 
fetuses. 
Results and Discussion 
Cultures enriched for astrocytes by serial passage were found 
to be >95%  GFAP +  (Fig.  1 a).  Two morphologically dis- 
Figure 1.  Immunocytochemical  analysis of 
human fetal  astrocytes.  (a) Methanol-fixed,  un- 
treated astrocytes  were tested for GFAP  immu- 
noreactivity. Cultures were >95%  GFAP  +. 
(b)  Methanol-fixed, TNF-treated  astrocytes 
were tested  for factor VIII-rehted antigen. As- 
trocytes  were negative  for this isotype  control. 
(c-J) Methanol-fixed,  untreated astrocytes  were 
tested  for  IG9,  E-Selectin, VCAM-1, and 
ICAM-1,  respectively. These cultures were 
negative for all four adhesion proteins. 
1632  Adhesion  Molecules and Astrocytes tinct populations could be detected: a flat attenuated form 
rich  in  GFAP +  cytoskeletal  fibers  and a  multipolar form 
with long GFAP § processes. TNF treatment for either 5 or 
16 h did not change this immunoreactivity  in either cell popu- 
lation. 
E-selectin  (34,  35) is a member of a family of inducible 
cell adhesion proteins whose carbohydrate ligands (36) are 
expressed by neutrophils, monocytes, and a subset of memory 
T cells. To test for the expression of E-selectin by astrocytes, 
cultures were treated with TNF for 5 h. These cultures ex- 
pressed E-selectin message (Fig.  2) and protein (Fig.  3 a). 
Similar results were obtained after TNF treatment of astro- 
cyte cultures for 16 h. Untreated astrocytes did not express 
E-selectin message (Fig.  2) or protein (Fig.  1 c). 
The expression of an adhesion molecule that was recently 
identified in our laboratory (3, Calderon et al.,  manuscript 
submitted for publication) was also studied, mAb IG9 in- 
hibits monocyte adhesion to TNF-treated EC. The 105-kD 
IG9 protein is not expressed on untreated EC but can be in- 
duced on the cell surface by TNF, II_,1, and LPS. Maximal 
expression is detected 4-9 h after stimulation and is no longer 
detectable after 48 h. Preclearance ofradiolabeled TNF-treated 
EC surface protein lysates by immunoprecipitation  with anti- 
E-selectin or anti-VCAM-1 antibodies does not diminish the 
levels of immunoprecipitable IG9 protein. These and other 
Figure 2.  Northern blot analysis of adhesion molecule expression by 
human fetal astrocytes. RNA from untreated or 5-h TNF-treated human 
fetal astrocytes was subjected to electropboresis through a 1% agarose gel, 
transferred to nitrocellulose, and probed using a 3ZP-labeled  eDNA probe 
for the indicated adhesion molecules. Untreated astrocytes expressed no 
E-selectin or ICAM-1 mRNA, whereas low levels of VCAM-1 message 
were detected. TNF-treated astrocytes expressed message for all three adhe- 
sion molecules. Filters were stripped of adhesion molecule probes and re- 
hybridized  with an 18S RNA probe  to demonstrate  equivalent  RNA 
loading. 
results (Calderon et al.,  manuscript submitted for publica- 
tion) suggest that the IG9 protein is a monocyte adhesion 
molecule distinct from E-selectin and VCAM-1. In the present 
study, astrocytes were treated with TNF for 5 or 16 h and 
assessed for IG9 immunoreactivity. IG9 protein expression 
was detected in TNF-treated astrocytes  (Fig.  2 b) but was 
absent in untreated cultures (Fig. 1 d). Unlike the other adhe- 
sion molecules examined, IG9 protein appeared to be differen- 
tially expressed on distinct populations of astrocytes as there 
was more immunoreactivity detected in the flatter popula- 
tion of cells when compared with the multipolar form. 
VCAM-1 (37, 38) is a member of the Ig supergene family. 
Its ligand, very late antigen 4, is expressed on lymphocytes 
and monocytes (39). Untreated astrocytes expressed low levels 
of VCAM-1 message (Fig. 2) and few cells were positive by 
immunocytochemistry (Fig.  1  e).  As  shown  in  Fig.  2, 
Northern blot analysis revealed detectable VCAM-1 message 
after 5 h of TNF stimulation; however, no immunoreactivity 
for VCAM-1 protein was detected at this time point. In con- 
trast, after treatment with TNF for 16 h, astrocytes expressed 
detectable VCAM-1 message and protein (Fig.  3 c). 
ICAM-1 is also a member of the Ig supergene family whose 
ligand, lymphocyte function antigen 1, is expressed on all 
leukocytes (31, 40). Previous studies have shown that TNF- 
treated astrocytes express ICAM-1 (23, 24). To confirm that 
human fetal cells would respond to TNF in a similar manner, 
fetal astrocytes were cultured in the presence of TNF for 5 
or 16 h and tested for ICAM-1 expression.  Untreated astro- 
cytes did not express ICAM-1 message (Fig.  2) or protein 
(Fig.  l J). As shown in Figs. 2 and 3 d, astrocytes expressed 
detectable ICAM-1 message and protein after  5 h  of TNF 
stimulation. Both message and protein were also detected at 
16 h. 
To determine the kinetics of adhesion molecule expression 
by astrocytes, a cell-based ELISA was performed. As shown 
in Fig. 4 and confirmed  by immunocytochemical  data presented 
above, E-selectin,  IG9, and ICAM-1 proteins were detected 
by 5 h after TNF stimulation, whereas a significant increase 
in VCAM-1 expression was not detected until 16 h after TNF 
stimulation. Maximal IG9 and E-selectin expression was de- 
tected at 4 h, whereas VCAM-1 and ICAM-1 reached peak 
expression at 16 h. In addition, IG9 expression was quantita- 
tively lower than E-selectin, VCAM-1, and ICAM-I. These 
latter kinetic data also confirm the immunocytochemical  ob- 
servations. 
The data reported in this communication support two con- 
clusions about leukocyte adhesion molecule expression  by 
human fetal astrocytes. The first is that this cell type can be 
induced to express adhesion molecules. Previous studies using 
cultured astrocytes (20, 23, 24) have demonstrated ICAM-1 
expression in vitro. In addition, studies examining in vivo 
expression of adhesion molecules in CNS inflammatory dis- 
eases have suggested that astrocytes may also express adhe- 
sion molecules (5, 12). Preliminary studies in our laboratory 
using double immunofluorescence colocalized  GFAP and 
VCAM-1 in active multiple sclerosis lesions.  Immunocyto- 
chemical and Northern blot analyses presented in the present 
1633  Hurwitz et al. Figure  3.  Immunocytochemical analysis of adhesion  molecule expression.  Methanol-fixed, TNF-treated (5 h: E-selectin,  IG9, and ICAM-1; 16 h: 
VCAM-1)  astrocytes were tested for adhesion molecule immunoreactivity. TNF-treated astrocytes expressed E-selectin (a), IG9 (b), VCAM-1 (c), and 
ICAM-1 (d) proteins. 
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Figure  4.  Kinetic analysis of adhesion molecule expression. Untreated 
or TNF-treated astrocytes were tested for adhesion  molecule expression. 
Astrocyte cultures were treated with TNF and fixed as described above. 
Immunoreactivity was detected using peroxidase/TMB and analyzed at 
OD 450 rim. Data (•  SD) are representative  of five experiments,  each 
using different  astrocyte  cultures. 
report  provide  evidence  for  the  expression  of E-selectin, 
IG9,  VCAM-1,  and  ICAM-1.  Second,  the  expression  of 
VCAM-1  and  ICAM-1  differs  from  that  detected on EC. 
While VCAM-1 protein is detected on EC after TNF treat- 
ment for 4 h  (37),  it was undetectable on astrocytes at this 
time point.  Although  ICAM-1  has been shown  to be ex- 
pressed constitutively at low levels on EC (31),  we demon- 
strate that untreated astrocytes expressed neither ICAM-1 mes- 
sage nor  protein. 
The results presented in this report further implicate as- 
trocytes in the immune response within the CNS. Accord- 
ingly, once monocytes and lymphocytes have crossed the BBB, 
their migration to sites of inflammation within the CNS pa- 
renchyma may be facilitated by astrocyte expression of adhe- 
sion molecules.  In diseases  such as AIDS or multiple  scle- 
rosis,  where  immune  cells  are  detected  within  the  CNS, 
adhesion molecule expression by astrocytes may function in 
such a manner. Current experiments designed to examine the 
in vivo expression of adhesion molecules by astrocytes during 
pathologic conditions should help to clarify the role of astro- 
cytes in  CNS inflammatory  disease. 
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